CTOR – citius oncology, inc. (US:NASDAQ)
Stock Stats
News
Citius Oncology, Inc. (NASDAQ: CTOR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock.
Form 4 CITIUS ONCOLOGY, INC. For: Dec 12 Filed by: Mayersohn Joel David
Form 4 CITIUS ONCOLOGY, INC. For: Dec 12 Filed by: Holuka Eugene Myron
Form 4 CITIUS ONCOLOGY, INC. For: Dec 12 Filed by: HOLUBIAK MYRON Z
Form 4 CITIUS ONCOLOGY, INC. For: Dec 12 Filed by: Dutia Suren G
Form 4 CITIUS ONCOLOGY, INC. For: Dec 12 Filed by: Smith Robert Joseph
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.